
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Zortress (Everolimus) is used to prevent the rejection of a kidney transplant. This is also used with other medications to prevent the rejection of a liver transplant. This is used in adult patients at low-moderate immunologic risk receiving a kidney transplant.
Zortress (Everolimus) lowers your body’s immune system. Your body fights infection through the help of your immune system. It can also ‘reject’ or fight a transplanted organ such as a liver or kidney. This is because the immune system treats the new organ as an invader.
This medication binds to the immunophilin FK Binding Protein-12to generate an immunosuppressive complex. It binds and inhibits the activation of the mammalian Target of Rapamycin. It is a key regulatory kinase. Inhibition of it results in the inhibition of T lymphocyte activation and inhibition of antibody production. It also results in proliferation associated with antigen and cytokine stimulation.
Zortress (Everolimus) belong to the class of drugs known as immunosuppressants. This comes as a tablet for oral administration. This drug has Everolimus as an active ingredient. Each tablet contains 0.25 mg, 0.5 mg, and 0.75 mg. The Food and Drug Administration (FDA) has already approved this medication.
This is to be taken by mouth with a full glass of water. It is usually taken every 12 hours. This medication is usually started 30 days after a liver transplant. You may take it with or without food. Swallow the drug as a whole. Do not break or chew the tablets. To help you remember, take it at the same time each day. The dosage is based on your medical condition and response.